Drug intelligence / Profile preview

Galectovid

Development stage
Unknown
Lead developer
Tollo Health
Modality
Small Molecules
Administration
Oral, Buccal
01

Overview

Galectovid is a proprietary medical food formulated as a peppermint-flavored chewable tablet designed to support the body’s natural defenses by targeting and reducing the activity of Galectin-1 and Galectin-3 proteins. These galectin proteins are implicated in chronic inflammation, immune system regulation, and viral infections. By acting as a galectin antagonist—specifically inhibiting both Galectin-1 and Galectin-3—Galectovid aims to limit viral invasion, reduce inflammation, and enhance immune response. The product is intended for dietary management of conditions associated with overexpression of these galectins, including chronic inflammatory states and persistent viral infections such as Long COVID. It is not classified as a pharmaceutical drug but rather as a medical food to be used under physician supervision[1][2][9].

Brand names
Galectovid
Other names
Galectovid
02

Targets

LGALS3 (Galectin-3)LGALS1 (Galectin-1)

Beyond the preview

Go deeper on Galectovid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galectovid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call